KAZIA PROVIDES OVERVIEW OF PAXALISIB RELATED PRESENTATIONS FROM THE SOCIETY OF NEURO-ONCOLOGY 2023 ANNUAL MEETING

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to provide key highlights of the clinical...

Related Keywords

United States ,San Francisco ,California ,Sydney ,New South Wales ,Australia ,America ,Sabine Mueller ,Brandon Imber ,Evangeliner Jackson ,Ryan Duchatel ,John Friend ,Twitter ,Memorial Sloan Kettering Cancer Center ,Prnewswire Kazia Therapeutics Limited ,Genentech ,University Of Newcastle ,Society Of Neuro ,Drug Administration ,Kazia Therapeutics Limited ,Therapeutics Limited ,Diffuse Midline ,North America ,Overall Survival ,Progression Free Survival ,Kazia Therapeutics ,Fast Track Designation ,Pediatric Disease ,